Stella Pharma
4888.TLOWScore: 21.5Nuclear Medicine / Fusion · Weight: 1%· Data as of 2026-04-21
Also in:Nuclear
¥525+2.14%
6-month dailyInvestment Thesis
World ONLY producer of pharmaceutical-grade boron drug (Steboronin) for BNCT cancer therapy. Japan is 5+ years ahead of any country. Micro-cap (12B), speculative but truly unique monopoly.
Risk
Loss-making biotech. PB 9x for money-losing company. Share dilution +4.1% YoY. BNCT adoption extremely slow. Speculative call option only.
Monitoring Trigger
BNCT treatment volume growth. International regulatory approvals.
Key Metrics
null
PE
null
Fwd PE
9.04
P/B
-9.8%
ROE
-23.6%
Op Margin
29%
D/E
0%
Div Yield
N/A
FCF
¥24.4B
Mkt Cap